Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34.
Kocarnik JM, Shiovitz S, Phipps AI. Molecular phenotypes of colorectal cancer and potential clinical applications. Gastroenterol Rep (Oxf). 2015;3(4):269–76.
Mitchell SF, Parker R. Principles and properties of eukaryotic mRNPs. Mol Cell. 2014;54(4):547–58.
Article CAS PubMed Google Scholar
Sternburg EL, Karginov FV. Global approaches in studying RNA-binding protein interaction networks. Trends Biochem Sci. 2020;45(7):593–603.
Article CAS PubMed Google Scholar
Gerstberger S, Hafner M, Tuschl T. A census of human RNA-binding proteins. Nat Rev Genet. 2014;15(12):829–45.
Article CAS PubMed PubMed Central Google Scholar
Shao Y, Chen C, Shen H, He BZ, Yu D, Jiang S, et al. GenTree, an integrated resource for analyzing the evolution and function of primate-specific coding genes. Genome Res. 2019;29(4):682–96.
Article CAS PubMed PubMed Central Google Scholar
Shivalingappa PKM, Sharma V, Shiras A, Bapat SA. RNA binding motif 47 (RBM47): emerging roles in vertebrate development, RNA editing and cancer. Mol Cell Biochem. 2021;476(12):4493–505.
Article CAS PubMed Google Scholar
Vanharanta S, Marney CB, Shu W, Valiente M, Zou Y, Mele A, et al. Loss of the multifunctional RNA-binding protein RBM47 as a source of selectable metastatic traits in breast cancer. Elife. 2014;3:3.
Sakurai T, Isogaya K, Sakai S, Morikawa M, Morishita Y, Ehata S, et al. RNA-binding motif protein 47 inhibits Nrf2 activity to suppress tumor growth in lung adenocarcinoma. Oncogene. 2016;35(38):5000–9.
Article CAS PubMed PubMed Central Google Scholar
Rokavec M, Kaller M, Horst D, Hermeking H. Pan-cancer EMT-signature identifies RBM47 down-regulation during colorectal cancer progression. Sci Rep. 2017;7(1):4687.
Article PubMed PubMed Central Google Scholar
Radine C, Peters D, Reese A, Neuwahl J, Budach W, Janicke RU, et al. The RNA-binding protein RBM47 is a novel regulator of cell fate decisions by transcriptionally controlling the p53–p21-axis. Cell Death Differ. 2020;27(4):1274–85.
Article CAS PubMed Google Scholar
Wei Y, Zhang F, Zhang Y, Wang X, Xing C, Guo J, et al. Post-transcriptional regulator Rbm47 elevates IL-10 production and promotes the immunosuppression of B cells. Cell Mol Immunol. 2019;16(6):580–9.
Article CAS PubMed Google Scholar
Mattick JS, Amaral PP, Carninci P, Carpenter S, Chang HY, Chen LL, et al. Long non-coding RNAs: definitions, functions, challenges and recommendations. Nat Rev Mol Cell Biol. 2023;24(6):430–47.
Article CAS PubMed PubMed Central Google Scholar
Statello L, Guo CJ, Chen LL, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021;22(2):96–118.
Article CAS PubMed Google Scholar
Badowski C, He B, Garmire LX. Blood-derived lncRNAs as biomarkers for cancer diagnosis: the Good, the Bad and the Beauty. NPJ Precis Oncol. 2022;6(1):40.
Article CAS PubMed PubMed Central Google Scholar
Conrad DF, Pinto D, Redon R, Feuk L, Gokcumen O, Zhang Y, et al. Origins and functional impact of copy number variation in the human genome. Nature. 2010;464(7289):704–12.
Article CAS PubMed Google Scholar
Hu X, Feng Y, Zhang D, Zhao SD, Hu Z, Greshock J, et al. A functional genomic approach identifies FAL1 as an oncogenic long noncoding RNA that associates with BMI1 and represses p21 expression in cancer. Cancer Cell. 2014;26(3):344–57.
Article CAS PubMed PubMed Central Google Scholar
Xu Y, Wu T, Li F, Dong Q, Wang J, Shang D, et al. Identification and comprehensive characterization of lncRNAs with copy number variations and their driving transcriptional perturbed subpathways reveal functional significance for cancer. Brief Bioinform. 2020;21(6):2153–66.
Article CAS PubMed Google Scholar
Liu H, Gu X, Wang G, Huang Y, Ju S, Huang J, et al. Copy number variations primed lncRNAs deregulation contribute to poor prognosis in colorectal cancer. Aging (Albany NY). 2019;11(16):6089–108.
Article CAS PubMed Google Scholar
Tyagi N, Roy S, Vengadesan K, Gupta D. Multi-omics approach for identifying CNV-associated lncRNA signatures with prognostic value in prostate cancer. Noncoding RNA Res. 2024;9(1):66–75.
Article CAS PubMed Google Scholar
Liu T, Liu Y, Su X, Peng L, Chen J, Xing P, et al. Genome-wide transcriptomics and copy number profiling identify patient-specific CNV-lncRNA-mRNA regulatory triplets in colorectal cancer. Comput Biol Med. 2023;153: 106545.
Article CAS PubMed Google Scholar
Redon R, Ishikawa S, Fitch KR, Feuk L, Perry GH, Andrews TD, et al. Global variation in copy number in the human genome. Nature. 2006;444(7118):444–54.
Article CAS PubMed PubMed Central Google Scholar
Han H, Wang S, Meng J, Lyu G, Ding G, Hu Y, et al. Long noncoding RNA PART1 restrains aggressive gastric cancer through the epigenetic silencing of PDGFB via the PLZF-mediated recruitment of EZH2. Oncogene. 2020;39(42):6513–28.
Article CAS PubMed Google Scholar
Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–504.
Article CAS PubMed PubMed Central Google Scholar
Pheatmap: Pretty Heatmaps. https://cran.r-project.org/web/packages/pheatmap/index.html.
Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284–7.
Article CAS PubMed PubMed Central Google Scholar
Enrichplot: visualization of functional enrichment result. https://bioconductor.org/packages/release/bioc/html/enrichplot.html.
Hong Y, Downey T, Eu KW, Koh PK, Cheah PY. A “metastasis-prone” signature for early-stage mismatch-repair proficient sporadic colorectal cancer patients and its implications for possible therapeutics. Clin Exp Metastasis. 2010;27(2):83–90.
Article CAS PubMed Google Scholar
Tsukamoto S, Ishikawa T, Iida S, Ishiguro M, Mogushi K, Mizushima H, et al. Clinical significance of osteoprotegerin expression in human colorectal cancer. Clin Cancer Res. 2011;17(8):2444–50.
Article CAS PubMed Google Scholar
Lin G, He X, Ji H, Shi L, Davis RW, Zhong S. Reproducibility Probability Score–incorporating measurement variability across laboratories for gene selection. Nat Biotechnol. 2006;24(12):1476–7.
Article CAS PubMed Google Scholar
Marisa L, de Reynies A, Duval A, Selves J, Gaub MP, Vescovo L, et al. Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value. PLoS Med. 2013;10(5): e1001453.
Article CAS PubMed PubMed Central Google Scholar
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-seque
Comments (0)